XSHG
603650
Market cap5.44bUSD
Oct 09, Last price
57.39CNY
1D
-2.84%
1Q
-30.65%
IPO
38.02%
Name
Red Avenue New Materials Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Red Avenue New Materials Group Co., Ltd. engages in the research, development, production, processing, and sales of fine chemical raw materials, chemical products, rubber and plastic processing aids, accelerators, microelectronic materials, and biodegradable plastic in China and internationally. The company offers resins, such as tackifying resin, P-tert-butyl Phenol formaldehyde tackifying resin, P-octyl Phenol formaldehyde tackifying resin, straight Phenol formaldehyde tackifying resin, tall oil modification Phenol formaldehyde resin, CNSL modified phenol formaldehyde reinforcing resin, and resorcinol formaldehyde resin, as well as curing, wet grp, anti-tear, tread, and sidewall resin. It also provides rubber processing aids, silica and functional additives, environment friendly chemical peptizer, anti-reversion agent, homogenizer, and coupling agent for CB; and vulcanizing agent, tackifier and silca activator, silica and silane, high styrene resin and antioxidant, rubber wax, tread grip resin, rubber additives, rubber environment-friendly oil, cobalt, and rayon. In addition, the company offers phenolic resin for CCL, LCD, and OLED; KrF DUV Photoresist, I/G line positive tone photoresist, thick film positive, lift off negative resist, BP positive resist, ArF, EBR, and PMA; high fine black photoresist for color filter, display resist or TFT-LCD, and AMOLED positive photoresist; biodegradable products for daily use, food contact, and agriculture applications; and other industrial products comprising P-Tert-Butylphenol, catalyst, and industrial phenolic resins. The company was founded in 1999 and is headquartered in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||